300149
vs
S
Shanghai Composite
300149
Over the past 12 months, ChemPartner PharmaTech Co Ltd has significantly outperformed Shanghai Composite, delivering a return of +92% compared to the Shanghai Composite's +27% growth.
Stocks Performance
300149 vs Shanghai Composite
Performance Gap
300149 vs Shanghai Composite
Performance By Year
300149 vs Shanghai Composite
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
ChemPartner PharmaTech Co Ltd
Glance View
ChemPartner PharmaTech Co., Ltd. engages in the research and development, production, and sale of prebiotic products. The company is headquartered in Guangzhou, Guangdong and currently employs 2,636 full-time employees. The company went IPO on 2010-12-22. The firm's main products include fructooligosaccharides and galactooligosaccharides. The firm owns brands names of FOS and GOS. The firm's products are mainly used in nutrition and health products, dairy products, beverages, baked goods, functional candy and snack foods. The firm distributes its products mainly in domestic market, with South China as its main market.
